it is concluded that the indication of the administration of isoniazid in leprosy is extremely limited and could only be envisaged as a companion drug in combined therapy of dapsone-resistant multibacillary leprosy in light-skinned people , when aminoglycosides can not be administered .
C0023343
leprosy
C1562585
multibacillary leprosy